Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06015932
What this trial is testing

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Mayo Clinic 400
Testing effectiveness (Phase 2)UnknownNCT03694249
What this trial is testing

Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence

Who this might be right for
Malignant Solid Tumor
Vanderbilt-Ingram Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Looking for participantsNCT05111561
What this trial is testing

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04317105
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm
National Cancer Institute (NCI) 54
Early research (Phase 1)Active Not RecruitingNCT05495295
What this trial is testing

First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours

Who this might be right for
Malignant TumorAdvanced Solid TumorGlioblastoma Multiforme+1 more
Phost'In Therapeutics 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068194
What this trial is testing

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Who this might be right for
Locally Advanced Malignant Solid NeoplasmLocally Advanced Unresectable CholangiocarcinomaLocally Advanced Unresectable Gallbladder Carcinoma+7 more
National Cancer Institute (NCI) 103
Early research (Phase 1)Study completedNCT04631029
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
National Cancer Institute (NCI) 3
Early research (Phase 1)WithdrawnNCT00886496
What this trial is testing

Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+4 more
Enzon Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Not applicableStudy completedNCT02111889
What this trial is testing

Tumor Kinase Inhibitor Concentrations Measured by PET

Who this might be right for
Disseminated Malignant Neoplasm
Amsterdam UMC, location VUmc 8
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Early research (Phase 1)Study completedNCT00576654
What this trial is testing

Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmTriple-Negative Breast Carcinoma+1 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT03678883
What this trial is testing

9-ING-41 in Patients With Advanced Cancers

Who this might be right for
CancerPancreatic CancerSarcoma+22 more
Actuate Therapeutics Inc. 350
Not applicableLooking for participantsNCT05530759
What this trial is testing

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMetastatic Malignant Solid Neoplasm
Mayo Clinic 50
Early research (Phase 1)Study completedNCT05082610
What this trial is testing

HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

Who this might be right for
CancerTumor, SolidNonsmall Cell Lung Cancer+4 more
Hummingbird Bioscience 48
Early research (Phase 1)Study completedNCT01417546
What this trial is testing

NHS-IL12 for Solid Tumors

Who this might be right for
Epithelial Neoplasms, MalignantEpithelial Tumors, MalignantMalignant Mesenchymal Tumor
National Cancer Institute (NCI) 72
Early research (Phase 1)Active Not RecruitingNCT05311397
What this trial is testing

A166 in Patients With Advanced Solid Malignant Tumors

Who this might be right for
Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Early research (Phase 1)Study completedNCT00535951
What this trial is testing

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Who this might be right for
Carcinoma, Non-Small-Cell LungMesothelioma
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Next Page